The BALANCE model, which stands for Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth, represented a structured attempt to provide GLP-1 access through government programs while controlling costs through direct manufacturer negotiation
Desde nuestra plataforma corporativa, las empresas pueden gestionar la salud de sus equipos con datos consolidados, anticipar riesgos y simplificar la medicina ocupacional gracias al expediente mdico electrnico
#obesity #glp1 #healthcareinnovation #healthcaredata Jonathan Rossmans Post Fun fact from a data deep dive that I helped work on: Medicaid spending on GLP-1s has grown exponentially over the past five years with 36 states now covering at least one of the FDA-approved GLP-1s for obesity (Wegovy, Zepbound, or Saxenda) Why
Key factors researchers consider include: The Model System: Is this for cell cultures (in-vitro) or animal models (in-vivo)
Recent reports of intestinal blockages have prompted the FDA to add a warning label on Ozempic, even though similar warnings are already present on Mounjaro and Wegovy
This includes improvements in fitness levels and nutrition, aligning with Minimals commitment to your holistic well-being